Medical Equipment

RNA Analysis/ Transcriptomics Market Outlook Highlighting Key Drivers And Market Evolution

April 15, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The RNA Analysis/ Transcriptomics Market Progress Between 2026 And 2030?

The rna analysis/ transcriptomics market has seen significant expansion in recent years. Its valuation is anticipated to rise from $8.74 billion in 2025 to $10.22 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.9%. This historical growth can be linked to the expansion of genomic research programs, increasing adoption of rna sequencing technologies, rising funding for life sciences research, availability of advanced laboratory instruments, and growing academic research activity.

The rna analysis/ transcriptomics market is anticipated to experience significant expansion in the coming years. Projections indicate it will reach $19.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.8%. This expansion during the projection period is primarily driven by factors such as the escalating demand for precision medicine, the expanding application of transcriptomics in drug discovery, the growth of clinical diagnostics utilizing gene expression, increasing capital directed towards bioinformatics infrastructure, and a heightened emphasis on personalized therapeutics. Key developments anticipated within this timeframe involve the wider acceptance of next-generation sequencing platforms, greater utilization of high-throughput transcriptomic profiling, the increasing integration of sophisticated bioinformatics tools, the broader deployment of single-cell rna analysis methods, and an intensified commitment to data accuracy and reproducibility.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Which Key Drivers Are Affecting The RNA Analysis/ Transcriptomics Market Development?

The RNA analysis/ transcriptomics market is anticipated to expand due to the increasing prevalence of chronic diseases. These conditions are defined as ailments lasting a year or more, interfering with daily activities, requiring continuous medical care, or both. The rising incidence of chronic diseases is primarily linked to increasingly sedentary lifestyles, where reduced daily physical activity compromises metabolic health and heightens the likelihood of developing long-term illnesses. RNA analysis/transcriptomics offers assistance in managing chronic diseases by uncovering changes in gene activity that drive the conditions, thereby facilitating earlier detection, more precise diagnosis, and the development of targeted, personalized treatments. For instance, in June 2024, the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, representing an 18% increase from 3,065,825 cases in 2022. Hence, the increasing occurrence of chronic diseases is a key driver for the expansion of the RNA analysis/ transcriptomics market.

What Are The Different Segment Types In The RNA Analysis/ Transcriptomics Market Segment Breakdown?

The rna analysis/ transcriptomics market covered in this report is segmented –

1) By Product: Reagents/Consumables, Instruments, Software

2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction

3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference

Subsegments:

1) By Reagents/Consumables: Nucleotides, Enzymes, Buffers and Solutions, Sample Preparation Kits, Sequencing Kits

2) By Instruments: Sequencers, Real-Time PCR Machines, Microarrays, Electrophoresis Systems, Robotic Liquid Handlers

3) By Software: Data Analysis Software, Bioinformatics Tools, Statistical Analysis Software, Visualization Software, Database Management Systems

What Trends Are Transforming The RNA Analysis/ Transcriptomics Market?

Leading companies operating in the RNA analysis/ transcriptomics market are increasingly concentrating on introducing innovative product lines to achieve a competitive advantage. This RNA Portfolio encompasses the creation of advanced technologies and solutions designed to enhance the efficiency and effectiveness of RNA analysis. For example, in May 2023, Twist Bioscience Corporation, a US-based biotechnology company, announced the introduction of a collection of RNA sequencing tools. This collection features specific target enrichment capabilities for RNA and whole transcriptome sequencing, alongside the Twist RNA Exome, Twist RNA Library Prep Kit, and Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit. The portfolio delivers complete workflows for analyzing messenger RNA (mRNA) protein coding sequences, custom targets, and total RNA, all aimed at measuring the transcriptome. Moreover, these offerings are capable of being integrated into the existing workflows of their clients.

Who Are The Well-Known Companies In The RNA Analysis/ Transcriptomics Market?

Major companies operating in the rna analysis/ transcriptomics market are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMérieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.

Get The Full RNA Analysis/ Transcriptomics Market Report:

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Where Is The RNA Analysis/ Transcriptomics Market Primarily Concentrated By Region?

North America was the largest region in the RNA analysis/transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rna analysis/ transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized RNA Analysis/ Transcriptomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Browse Through More Reports Similar to the Global RNA Analysis/ Transcriptomics Market 2026, By The Business Research Company

Rna Sequencing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Ngs Based Rna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Ribonucleic Acid Rna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795